Section Arrow
Quote
KNSA.NASDAQ
- Kiniksa Pharmaceuticals International plc
Quotes are at least 15-min delayed:2025/09/14 12:25 EDT
Regular Hours
Last
 37.1
+0.09 (+0.24%)
Day High 
37.3394 
Prev. Close
37.01 
1-M High
37.25 
Volume 
396.32K 
Bid
37
Ask
37.12
Day Low
36.4 
Open
37.02 
1-M Low
32.06 
Market Cap 
2.74B 
Currency USD 
P/E 745.6 
%Yield -- 
10-SMA 35.46 
20-SMA 34.45 
50-SMA 31.56 
52-W High 37.3394 
52-W Low 17.82 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.05/--
Enterprise Value
2.75B
Balance Sheet
Book Value Per Share
6.68
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
423.24M
Operating Revenue Per Share
3.36
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands1.12+0.06+5.66%-- 
IXHLIncannex Healthcare0.5475+0.0175+3.30%-- 
CGCCanopy Growth Corp1.37-0.02-1.44%-- 
VTRSViatris9.96-0.21-2.06%227.2PE
TEVATeva Pharmaceutical Industries Limited19.93+0.04+0.20%-- 
Quotes are at least 15-min delayed：2025/09/14 12:25 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.